Effects of topically applied tocotrienol on cataractogenesis and lens redox status in galactosemic rats

Molecular Vision

Volumn 20, Issue , 2014, Pages 822-835

  Abdul Nasir, Nurul Alimah ^a   Agarwal, Renu ^a   Vasudevan, Sushil ^a   Tripathy, Minaketan ^a   Alyautdin, Renad ^a   Mohd Ismail, Nafeeza ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; CATALASE; GLUTATHIONE; LENS PROTEIN; LIPOSOME; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTERIOR EYE SEGMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GALACTOSEMIA; LENS; MICROEMULSION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SLIT LAMP;

ADMINISTRATION, TOPICAL; ANIMALS; ANTERIOR EYE SEGMENT; CATALASE; CATARACT; DISEASE PROGRESSION; EMULSIONS; EYE PROTEINS; GALACTOSEMIAS; GLUTATHIONE; LENS, CRYSTALLINE; LIPOSOMES; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; STATIC ELECTRICITY; STRESS, PHYSIOLOGICAL; SUPEROXIDE DISMUTASE; TOCOTRIENOLS; TYROSINE; VISCOSITY;

EID: 84902343353     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012; 96:614-8. [PMID: 22133988].
2. Rao GN, Khanna R, Payal A. The global burden of cataract. Curr Opin Ophthalmol 2011; 22:4-9. [PMID: 21107260].
3. Stambolian D. Galactose and cataract. Surv Ophthalmol 1988; 32:333-49. [PMID: 3043741].
4. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 1995; 9:1173-82. [PMID: 7672510].
5. Ottonello S, Foroni C, Carta A, Petrucco S, Maraini G. Oxidative stress and age-related cataract. Ophthalmologica 2000; 214:78-85. [PMID:10657746].
6. Vinson JA. Oxidative stress in cataracts. Pathophysiology 2006; 13:151-62. [PMID: 16765571].
7. Ito Y, Nabekura T, Takeda M, Nakao M, Terao M, Hori R, Tomohiro M. Nitric oxide participates in cataract development in selenite-treated rats. Curr Eye Res 2001; 22:215-20. [PMID: 11462158].
8. Inomata M, Hayashi M, Shumiya S, Kawashima S, Ito Y. Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR). Curr Eye Res 2001; 23:307-11. [PMID: 11852433].
9. Kim J, Kim CS, Sohn E, Kim H, Jeong IH, Kim JS. Lens epithelial cell apoptosis initiates diabetic cataractogenesis in the Zucker diabetic fatty rat. Graefes Arch Clin Exp Ophthalmol 2010; 248:811-8. [PMID: 20162295].
10. Ornek K, Karel F, Büyükbingöl Z. May nitric oxide molecule have a role in the pathogenesis of human cataract? Exp Eye Res 2003; 76:23-7. [PMID: 12589772].
11. Nagai N, Liu Y, Fukuhata T, Ito Y. Inhibitors of inducible nitric oxide synthase prevent damage to human lens epithelial cells induced by interferon-gamma and lipopolysaccharide. Biol Pharm Bull 2006; 29:2077-81. [PMID: 17015954].
12. Tan AG, Mitchell P, Flood VM, Burlutsky G, Rochtchina E, Cumming RG, Wang JJ. Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study. Am J Clin Nutr 2008; 87:1899-905. [PMID: 18541583].
13. Ugboaja OC, Bielory L, Bielory BP, Ehiorobo ES. Antioxidant vitamins, minerals and cataract: current opinion. Curr Opin Allergy Clin Immunol 2012; 12:517-22. [PMID: 22885892].
14. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922; 56:650-1. [PMID: 17838496].
15. Gupta PP, Pandey DJ, Sharma AL, Srivastava RK, Mishra SS. Prevention of experimental cataract by alpha-tocopherol. Indian J Exp Biol 1984; 22:620-2. [PMID: 6534851].
16. Ohta Y, Yamasaki T, Niwa T, Majima Y. Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet. J Ocul Pharmacol Ther 2000; 16:323-35. [PMID: 10977128].
17. Ayala MN, Söderberg PG. Vitamin E can protect against ultraviolet radiation-induced cataract in albino rats. Ophthalmic Res 2004; 36:264-9. [PMID: 15583432].
18. Leske MC, Chylack LT Jr, He Q, Wu SY, Schoenfeld E, Friend J, Wolfe J. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology 1998; 105:831-6. [PMID: 9593382].
19. Mares-Perlman JA, Lyle BJ, Klein R, Fisher AI, Brady WE, Vanden Langenberg GM, Trabulsi JN, Palta M. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000; 118:1556. [PMID: 11074813].
20. McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 2004; 111:75-84. [PMID: 14711717].
21. Dunphy PJ, Whittle KJ, Pennock JF, Morton RA. Identification and estimation of tocotrienols in Hevea latex. Nature 1965; 207:521-2.
22. Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE, Packer L. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: Implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993; 32:10692-9. [PMID: 8399214].
23. Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Asp Med 2007; 28:692-728. [PMID: 17507086].
24. Yoshida Y, Saito Y, Jones LS, Shigeri Y. Chemical reactivities and physical effects in comparison between tocopherols and tocotrienols: physiological significance and prospects as antioxidants. J Biosci Bioeng 2007; 104:439-45. [PMID: 18215628].
25. Zielinski H. Tocotrienols: Distribution and Sources Cereals-Role in Human Health. In: Watson RR, Preedy VR, editors. Tocotrienols: Vitamin E beyond Tocopherols. 1st ed. Florida: CRC Press; 2009. p. 23-42.
26. Frega N, Mozzon M, Bocci F. Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography-mass spectrometry. J Am Oil Chem Soc 1998; 75:1723-7.
27. Tan B, Foley J. inventors; American River Nutrition, Inc., assignee. Tocotrienols and geranylgeraniol from Bixa orellana byproducts. United States patent US 6,350,453. 2002 Feb 26.
28. Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr 1996; 126:389-94. [PMID: 8632210].
29. Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Asai A, Miyazawa T. α-Tocopherol attenuates the cytotoxic effect of δ-tocotrienol in human colorectal adenocarcinoma cells. Biochem Biophys Res Commun 2010; 397:214-9. [PMID: 20493172].
30. Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 1991; 10:263-75. [PMID: 1649783].
31. Serbinova EA, Packer L. Antioxidant properties of α-tocopherol and α-tocotrienol. Methods Enzymol 1994; 234:354-66. [PMID: 7808307].
32. Newaz MA, Yousefipour Z, Nawal NN, Adeeb N. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol. J Physiol Pharmacol 2003; 54:319-27. [PMID: 14566071].
33. Qureshi AA, Reis JC, Qureshi N, Papasian CJ, Morrison DC, Schaefer DM. δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis 2011; 10:39-42. [PMID: 21356098].
34. Ohta Y, Yamasaki T, Niwa T, Goto H, Majima Y, Ishigruo I. Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage. Ophthalmic Res 1999; 31:321-31. [PMID: 10420116].
35. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999; 13:23-30. [PMID: 9872926].
36. Bron AJ, Sparrow J, Brown NAP, Harding JJ, Blakytny R. The lens in diabetes. Eye (Lond) 1993; 7:260-75. [PMID: 7607346].
37. Monnier VM, Stevens VJ, Cerami A. Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J Exp Med 1979; 150:1098-107. [PMID: 501285].
38. Kinoshita JH, Merola LO, Dikmak E. Osmotic changes in experimental galactose cataracts. Exp Eye Res 1962; 1:405-10. [PMID: 14032902].
39. Valdivia FJG, Dachs AC, Perdiguer NC. inventors; Laboratorios Cusi, S.A., assignee. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof. United States patent US 5,698,219. 1997 Dec 16.
40. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I. Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 2005; 59:177-87. [PMID: 15567316].
41. Agarwal R, Iezhitsa I, Awaludin NA, Ahmad Fisol NF, Bakar NS, Agarwal P, Abdul Rahman TH, Spasov A, Ozerov A, Mohamed Ahmed Salama MS, Ismail NM. Effects of magnesium taurate on the onset and progression of galactose induced experimental cataract: In vivo and in vitro evaluation. Exp Eye Res 2013; 110:35-43. [PMID: 23428743].
42. Vats V, Yadav SP, Biswas NR, Grover JK. Anti-cataract activity of Pterocarpus marsupium bark and Trigonella foenum-graecum seeds extract in alloxan diabetic rats. J Ethnopharmacol 2004; 93:289-94. [PMID: 15234767].
43. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502-22. [PMID: 4388022].
44. Burton GW, Ingold KU. Autooxidation of Biological Molecules. 1. The Antioxidant Activity of Vitamin E and Related Chain-Breaking Phenolic Antioxidants in vitro. J Am Chem Soc 1981; 103:6472-7.
45. Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996; 31:671-701. [PMID: 8827691].
46. Kowluru RA, Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med 1999; 26:371-8. [PMID: 9895229].
47. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17:24-38. [PMID: 12616644].
48. Ramana BV, Kumar VV, Krishna PNR, Kumar CS, Reddy PUM, Raju TN. Effect of quercetin on galactose-induced hyperglycaemic oxidative stress in hepatic and neuronal tissues of Wistar rats. Acta Diabetol 2006; 43:135-41. [PMID: 17211565].
49. Jumbo-Lucioni PP, Hopson ML, Hang D, Liang Y, Jones DP, Fridovich-Keil JL. Oxidative stress contributes to outcome severity in a Drosophila Melanogaster model of classic galactosemia. Dis Model Mech 2013; 6:84-94. [PMID: 22773758].
50. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005; 80:709-25. [PMID: 15862178].
51. Marsili S, Salganik RI, Albright CD, Freel CD, Johnsen S, Peiffer RL, Joseph Costello M. Cataract formation in a strain of rats selected for high oxidative stress. Exp Eye Res 2004; 79:595-612. [PMID: 15500819].
52. Kaur J, Kukreja S, Kaur A, Malhotra N, Kaur R. The Oxidative Stress in Cataract Patients. J Clin Diagn Res 2012; 6:1629-[PMID: 23373015].
53. Agarwal R, Iezhitsa IN, Agarwal P, Spasov AA. Mechanisms of cataractogenesis in the presence of magnesium deficiency. Magnes Res 2013; 26:2-8. [PMID: 23708888].
54. Allen DW, Jandl JH. Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols in oxidant drug action. J Clin Invest 1961; 40:454-[PMID: 13682509].
55. Beutler E. The glutathione instability of drug sensitive red cells: A new method for the in vitro detection of drug sensitivity. J Lab Clin Med 1957; 49:84-95. [PMID: 13385579].
56. Donma O, Yorulmaz E, Pekel H, Suyugül N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr Eye Res 2002; 25:9-16. [PMID: 12518238].
57. Manuely Keenoy BM, Moorkens G, Vertommen J, Noe M, Nève J, De Leeuw I. Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 2000; 19:374-82. [PMID: 10872900].
58. Wu SJ, Liu PL, Ng LT. Tocotrienol rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res 2008; 52:921-9. [PMID: 18481320].
59. Yam ML, Hafid SRA, Cheng HM, Nesaretnam K. Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264. 7 macrophages. Lipids 2009; 44:787-97. [PMID: 19655189].
60. Agarwal R, Iezhitsa I, Agarwal P, Spasov A. Magnesium deficiency: Does it have a role to play in cataractogenesis? Exp Eye Res 2012; 101:82-9. [PMID: 22668657].
61. Mazlan M, Then SM, Mat Top G, Zurinah Wan Ngah W. Comparative effects of α-tocopherol and γ-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J Neurol Sci 2006; 243:5-12. [PMID: 16442562].
62. Abd Manan N, Mohamed N, Shuid AN. Effects of Low-Dose versus High-Dose γ-Tocotrienol on the Bone Cells Exposed to the Hydrogen Peroxide-Induced Oxidative Stress and Apoptosis. Evid Based Complement Alternat Med 2012; 2012:680834-[PMID: 22956976].
63. Khor H, Theng NT, Rajendran R. Dose-Dependent Cholesterolemic Activity of Tocotrienols and α-Tocopherol. Malays J Nutr 2002; 8:157-66. [PMID: 22692474].
64. Qureshi AA, Sami SA, Salser WA, Khan FA. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002; 161:199-207. [PMID: 11882333].
65. Qureshi AA, Peterson DM, Hasler-Rapacz JO, Rapacz J. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 2001; 131:223-30. [PMID: 11160537].
66. Cillard J, Cillard P, Cormier M, Girre L. α-Tocopherol prooxidant effect in aqueous media: increased autoxidation rate of linoleic acid. J Am Oil Chem Soc 1980; 57:252-5.
67. Makpol S, Abidin AZ, Sairin K, Mazlan M, Top GM, Ngah WZW. γ-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals. Oxid Med Cell Longev 2010; 3:35-43. [PMID: 20716926].
68. Lim JJ, Wan Ngah WZ, Mouly V, Abdul Karim N. Reversal of Myoblast Aging by Tocotrienol Rich Fraction Posttreatment. Oxid Med Cell Longev 2013; 2013:978101-[PMID: 24349615].
69. Mazlan M. Comparison of the effects of α-tocopherol and γ-tocotrienol against oxidative stress in two different neuronal cultures. Sains Malays 2010; 39:145-56.
70. Hironaka K, Inokuchi Y, Tozuka Y, Shimazawa M, Hara H, Takeuchi H. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release 2009; 136:247-53. [PMID: 19272407].
71. Cortesi R, Esposito E, Maietti A, Menegatti E, Nastruzzi C. Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion. Int J Pharm 1997; 159:95-103.
72. Abramović Z, Šuštaršič U, Teskač K, Šentjurc M, Kristl J. Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation. Int J Pharm 2008; 359:220-7. [PMID: 18472233].